ORCHID PHARMA Share Price

ORCHID PHARMA Share Price

NSE: ORCHPHARMA
|
Pharmaceuticals
|
S Cap
₹ 1,096.35
-₹10.85 (-0.98%)
1D
Last updated 23 Sep, 2026, 13:34 IST

ORCHID PHARMA Share Price Today

As of 23 Sep 2026, ORCHID PHARMA share price is ₹1,096.35. The stock opened at ₹1,105.00, compared to its previous close of ₹1,107.20. During today's trading session, ORCHID PHARMA share price moved in the range of ₹1,095.05 to ₹1,129.20, with an average price of ₹1,112.13 for the day. Looking at its last 52-week, the stock has touched a low of ₹480.00 and a high of ₹1,143.50. On the performance front, ORCHID PHARMA share price has increased by 107.91% over the last six months and is up 44.48% on a year-on-year basis.

₹1,095.05
0.98% down today
₹1,129.20
1D LOW
1D HIGH

ORCHID PHARMA Returns Calculator

Circuit
L
H
₹885.80
₹1,328.60
52-week
L
H
₹480.00
₹1,143.50

About ORCHID PHARMA

ORCHID PHARMA Share Price
ISIN
INE191A01027
Sector Market Cap
₹ 6,476.28 Cr

Orchid Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of formulations and active pharmaceutical ingredients (API). It operates through the pharmaceutical segment. It has a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (APIs) and finished dosage forms. It offers APIs, including Cephalosporins-Orals, Cephalosporins-Injectables, and Veterinary Products. Its formulations include Cefixime Capsules, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets and Cefoperazone and Sulbactam for Injection, among others. Its subsidiaries include Orchid Bio-Pharma Limited, Orchid Pharmaceuticals Inc., Bexel Pharmaceuticals Inc. and Diakron Pharmaceuticals, Inc.

ORCHID PHARMA Financial Highlights

  • Revenue: ORCHID PHARMA reported revenue of ₹1,269.20 crore in FY26 vs ₹949.40 crore in FY25. It showed an increase of 33.68% on a yearly basis.
  • Operating Profit: ORCHID PHARMA reported an operating profit of ₹10.43 crore in FY26 vs ₹95.56 crore in FY25. It showed a decrease of 89.09% on a year-on-year basis.
  • Net Profit: ORCHID PHARMA reported a net profit of ₹10.62 crore in FY26 vs ₹95.76 crore in FY25. It showed a decrease of 88.91% on a yearly basis.

ORCHID PHARMA Quarterly Result Highlights

  • ORCHID PHARMA reported revenue of ₹306.00 crore in Jun 2026, compared with ₹376.10 crore in Mar 2026, representing a decrease of 18.64% on a quarter-on-quarter (QoQ) basis.
  • ORCHID PHARMA reported an operating profit of ₹2.65 crore in Jun 2026, compared with ₹24.85 crore in Mar 2026, representing a decrease of 89.34% on a quarter-on-quarter (QoQ) basis.
  • ORCHID PHARMA reported a profit of ₹2.58 crore in Jun 2026, compared with ₹24.84 crore in Mar 2026, reflecting a decrease of 89.61% on a QoQ basis.
  • The earnings per share (EPS) of ORCHID PHARMA stood at ₹1.66 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
69.84%
FII
0.81%
Other DII
0.82%
Retail and other
8.61%
Mutual funds
19.93%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20251.56%
Dec 20251.17%
Mar 20260.87%
Jun 20260.81%
Mkt Cap Cr
6,630.49
P/E
618.55
P/B
4.24
ROE
1.34%
D/E
0.13
ROCE
1.62%
Div. Yield
0.00%
EPS(TTM)
5.78
Turnover
0.61
EV/EBITDA
106.54
Net Margin
3.83%
Op. Margin
8.11%
ROA
0.62%
Quick Ratio
1.29
Curr. Ratio
3.50
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Orchid Pharma outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Orchid Pharma appears overvalued compared to its peers
Step 2 of 5
Earnings
Poor
Orchid Pharma earnings have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

ORCHID PHARMA Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,232.78₹1,397.61₹819.37₹665.90
Other Income₹36.42₹31.98₹30.86₹19.43
Total Revenue₹1,269.20₹1,429.59₹850.23₹685.33
Total Expenses₹1,251.44₹1,308.06₹758.29₹669.29
Profit Before Tax₹10.43₹121.53₹91.95₹55.25
Tax-₹0.19-₹9.64-₹3.12₹0.00
Profit After Tax₹10.62₹131.17₹95.06₹55.25
EPS - Basic₹1.66₹22.55₹19.06₹11.35
EPS - Diluted₹1.66₹22.55₹19.06₹11.35

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹10.43₹121.53₹89.05₹46.32
Income before WC changes₹52.41₹161.85₹133.20₹97.70
Change in Assets₹27.32-₹66.52-₹55.43-₹87.17
Change in Liabilities₹43.56-₹28.81₹47.59₹8.10
Change in WC₹70.88-₹95.33-₹7.84-₹79.06
Cash flow from Operations₹125.64₹51.37₹125.99₹18.34
Cash flow from Investing-₹276.88-₹36.48-₹312.03-₹31.21
Cash flow from Financing₹137.14₹2.46₹167.04₹31.17
Total Cash Flow-₹14.10₹17.34-₹19.00₹18.29
Cash (Start of the year)₹21.18₹3.83₹22.60₹4.31
Cash (End of the year)₹7.07₹21.18₹3.60₹22.60

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,329.16₹979.84₹763.12₹724.20
Current Assets₹929.26₹1,097.53₹790.75₹501.01
Total Assets₹2,258.43₹2,077.37₹1,553.87₹1,225.21
Current Liabilities₹491.21₹508.66₹259.97₹371.89
Net Current Asset₹438.05₹588.87₹530.78₹129.12
Non-Current Liabilities₹202.91₹14.77₹124.43₹164.67
Equity Capital₹1,564.31₹1,553.93₹1,169.47₹688.65
Total Equity & Liabilities₹2,258.43₹2,077.37₹1,553.87₹1,225.21

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,232.78₹1,397.61₹819.37₹665.90
Other Income₹56.49₹36.43₹30.39₹19.43
Total Revenue₹1,289.27₹1,434.04₹849.76₹685.33
Total Expenses₹1,247.31₹1,301.60₹758.23₹669.29
Profit Before Tax₹34.62₹132.45₹91.52₹55.25
Tax₹0.00-₹9.45-₹3.23₹0.00
Profit After Tax₹34.62₹141.90₹94.75₹55.25
EPS - Basic₹5.78₹23.69₹19.59₹13.28
EPS - Diluted₹5.78₹23.69₹19.59₹13.28

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹34.62₹132.45₹91.52₹54.19
Income before WC changes₹61.33₹167.07₹133.21₹108.29
Change in Assets₹52.23-₹61.78-₹45.55-₹104.38
Change in Liabilities₹26.47-₹26.61₹42.33₹9.78
Change in WC₹78.70-₹88.39-₹3.22-₹94.60
Cash flow from Operations₹142.42₹63.54₹130.73₹13.39
Cash flow from Investing-₹116.32-₹50.80-₹315.81-₹26.70
Cash flow from Financing-₹40.74₹2.68₹167.07₹31.17
Total Cash Flow-₹14.64₹15.41-₹18.01₹17.86
Cash (Start of the year)₹15.94₹0.53₹18.31₹0.45
Cash (End of the year)₹1.30₹15.94₹0.29₹18.31

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,216.19₹1,009.49₹769.91₹729.46
Current Assets₹881.44₹1,076.54₹782.29₹493.79
Total Assets₹2,097.63₹2,086.03₹1,552.20₹1,223.26
Current Liabilities₹395.04₹460.52₹209.67₹326.63
Net Current Asset₹486.40₹616.02₹572.62₹167.16
Non-Current Liabilities₹55.92₹14.77₹124.21₹164.67
Equity Capital₹1,646.68₹1,610.74₹1,218.32₹731.96
Total Equity & Liabilities₹2,097.63₹2,086.03₹1,552.20₹1,223.26
* All values are in INR Crore
Qty
Bid
2
1096.35
2
1096
7
1095.95
6
1095.9
10
1095.75
Ask
Qty
1097.05
2
1097.1
2
1097.15
11
1097.2
1
1097.25
6
Bid Total: 27
Ask Total: 22
Buy orders: 55%
Sell orders: 45%
Bearish
4
Neutral
3
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
65.99
Neutral
ATR (14)
48.06
Neutral
STOCH(9,6)
81.22
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
30.26
Bearish
UO(9)
51.29
Neutral
ROC(12)
18.46
Bullish
WillR(14)
-17.09
Bearish
Period
Simple value
Exponential vaue
5D
1018.85
1044.49
10D
1009.23
1017.43
20D
985.09
1001.94
50D
1004.29
981.19
100D
924.09
920.65
Volume trend — traded volume by day
23 Sep0L
22 Sep4L
21 Sep5L
18 Sep0L
17 Sep1L
16 Sep0L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
ORCHID PHARMA Share Price
ORCHID PHARMA
Pharmaceuticals
Add Stock
Add Another

ORCHID PHARMA Share Price FAQs

ORCHID PHARMA share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837